EFL009
Join host Dr. Chase Hendrickson, Vanderbilt University Medical Center, Dr. Alan Dalkin, Professor of Medicine and Vice Chairman for the Department of Medicine at the University of Virginia, and Dr. Dolores Shoback, Professor of Medicine and Staff Endocrinologist at the San Francisco Veterans Affairs Medical Center and Associate Director of Fellowship at the University of California, San Francisco, as they discuss a recent The Journal of Clinical Endocrinology & Metabolism (JCEM) article, “Use of Preoperative Imaging in Primary Hyperparathyroidism.”
Meet the Speakers
Dolores Shoback, MD, graduated from the Johns Hopkins University School of Medicine in 1977. She trained in Internal Medicine at the Johns Hopkins Hospital on the Osler Medical Service before completing a clinical and research fellowship in Endocrinology/Hypertension at Harvard Medical School in 1983. She joined the faculty of the University of California, San Francisco in 1985 in the Department of Medicine where she is currently Professor of Medicine and Staff Endocrinologist at the San Francisco Veterans Affairs Medical Center and Associate Director of the Diabetes, Endocrinology and Metabolism Fellowship Training Program at UCSF. She is engaged in research on the mechanisms underlying the regulation of parathyroid hormone secretion with specific interest in the role of calcium-sensing receptors in parathyroid cells and osteoblasts. Her clinical activities and clinical research interests focus on metabolic bone diseases, parathyroid disorders, and osteoporosis. She has participated in investigations into the role of calcium receptor activation in the control of parathyroid hormone hypersecretion due to primary hyperparathyroidism and parathyroid carcinoma and in clinical trials on the use of parathyroid hormone in the treatment of osteoporosis and as replacement therapy in the treatment of hypoparathyroidism. She has co-authored over 130 papers, reviews, and editorials. She is currently Secretary-Treasurer of the Endocrine Society (2019-2022). She has participated in the development of guidelines for the management of primary hyperparathyroidism (2008, 2013), for pharmacologic treatment of postmenopausal osteoporosis for the Endocrine Society (2013-20), and for management of hypoparathyroidism in adults (2013-2015).
Alan Dalkin, MD, completed medical school at the University of Michigan, residency in Internal Medicine at the University of Chicago, and then fellowship in Endocrinology at the University of Michigan. Dr. Dalkin served as faculty at University of Michigan before becoming a Professor of Medicine at the University of Virginia. He also serves as Vice Chairman for the Department of Medicine at the University of Virginia, in which he leads efforts around faculty development. Previously, Dr. Dalkin was the Fellowship Program Director at UVa, and has held numerous positions in the Association of Program Directors in Endocrinology and Metabolism. Dr. Dalkin has served on the Residency Review Committee for The American Council on Graduate Medical Education. He also leads the annual production of educational and testing products for the Endocrine Society. His clinical work is predominantly in the area of metabolic bone disease with an emphasis on osteoporosis and hyperparathyroidism. Dr. Dalkin has been recognized for his clinical work with a number of awards including departmental recognition such as Attending of the Year, and was selected to America’s Top Doctors and Best Doctors in America along with being recognized with an award for Best Bedside Manner. He has published numerous articles in peer-reviewed journals such as Endocrinology, Biology of Reproduction, and The Journal of Clinical Endocrinology & Metabolism. He has authored a number of invited reviews in the area of osteoporosis. Dr. Dalkin has been invited to deliver numerous local, state-wide and national presentations in the area of osteoporosis, metabolic bone disease, and disorders of vitamin D.
Resources